James Blair
QuietNamed in filings at Domain PartnersOn the current fund
- Board seats filed
- 11
- Named on a board
- 0
all filings on record
Named in filings at Domain PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| CARROT LABS | AI & machine learning | June 2024 | None on file |
| InflammX Therapeutics | Biotech & pharma | December 2020 | None on file |
| Fusion Ed | Education | April 2018 | None on file |
| ChromaCode | Biotech & pharma | April 2017 | None on file |
| Gene Sciences | Biotech & pharma | November 2016 | None on file |
| AXIAL BIOTHERAPEUTICS | Biotech & pharma | November 2016 | None on file |
| Triad Bancorp | Fintech | November 2015 | None on file |
| aTYR PHARMA | Biotech & pharma | March 2015 | Chemistry Ventures, Polaris Partners |
| Wireless Diagnostic Systems | Not yet classified | August 2014 | None on file |
| CoDa Therapeutics | Biotech & pharma | May 2014 | None on file |
| Astute Medical | Biotech & pharma | January 2014 | MPM BioVentures |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name James Blair on the board, based on 10 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.